Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Lett Appl Microbiol ; 54(1): 45-51, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22044343

RESUMO

AIMS: The application of Ralstonia eutropha H16 for producing polyhydroxyalkanoates as bioplastics is limited by the incapability of the bacterium to utilize glucose as a growth substrate. This study aims in characterizing glucose-utilizing strains that arose after incubation with high glucose levels, in comparison with previously published mutants, generated either by mutagenesis or by metabolic engineering. METHODS AND RESULTS: Cultivations on solid and liquid media showed that the application of high substrate concentrations rapidly induced a glucose-positive phenotype. The time span until the onset of growth and the frequency of glucose-utilizing colonies were correlated to the initial glucose concentration. All mutants exhibited elevated activities of glucose-6-phosphate dehydrogenase. The glucose-positive phenotype was abolished after deleting genes for the N-acetylglucosamine phosphotransferase system. CONCLUSIONS: A procedure is provided for selecting glucose-utilizing R. eutropha H16 in an unprecedented short time period and without any mutagenic treatment. An altered N-acetylglucosamine phosphotransferase system appears to be a common motif in all glucose-utilizing mutants examined so far. SIGNIFICANCE AND IMPACT OF THE STUDY: The correlation of the applied glucose concentration and the appearance of glucose-utilizing mutants poses questions about the randomness or the specificity of adaptive mutations in general. Furthermore, glucose-adapted strains of R. eutropha H16 could be useful for the production of bioplastics.


Assuntos
Cupriavidus necator/genética , Cupriavidus necator/metabolismo , Glucose/metabolismo , Microbiologia Industrial , Poli-Hidroxialcanoatos/biossíntese , Acetilglucosamina/metabolismo , Reatores Biológicos , Cupriavidus necator/classificação , Cupriavidus necator/crescimento & desenvolvimento , Glucosefosfato Desidrogenase/metabolismo , Engenharia Metabólica , Fosfotransferases/metabolismo , Plásticos/metabolismo
2.
J Biotechnol ; 150(3): 396-403, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20933549

RESUMO

The GUT1 gene of the halotolerant yeast Pichia farinosa, encoding glycerokinase (EC 2.7.1.30), was expressed in Pichia pastoris. A purification factor of approximately 61-fold was achieved by a combination of nickel affinity and anion exchange chromatography. The specific activity of the final preparation was 201.6 units per mg protein with a yield of about 21%. A nearly homogeneous enzyme preparation was confirmed by SDS-polyacrylamide gels and mass spectrometry analysis. Glycerol stabilized the purified enzyme for long-term storage at -80°C. The pH and temperature optima were in the range of 6.5-7.0 and 45-50°C, respectively. ATP was the most effective phosphoryl group donor tested. Additionally, the enzyme phosphorylated glycerol also with ITP, UTP, GTP and CTP. The K(m) values of the enzyme for ATP and ITP were 0.428 and 0.845 mM, respectively. The kinetic properties of the enzyme with respect to UTP, GTP, and CTP suggested that glycerokinase exhibited negative cooperativity as double reciprocal plots showed a biphasic response to increasing nucleoside triphosphate concentrations. The application as a coupling enzyme in the determination of pyruvate kinase activity in cell extracts of Madin-Darby canine kidney cells showed good reproducibility when compared with a commercially available preparation of bacterial glycerokinase.


Assuntos
Proteínas Fúngicas/metabolismo , Glicerol Quinase/metabolismo , Pichia/metabolismo , Proteínas Recombinantes de Fusão/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Contagem de Células , Extratos Celulares , Linhagem Celular , Cromatografia de Afinidade , Cromatografia por Troca Iônica , Cães , Ensaios Enzimáticos , Proteínas Fúngicas/química , Proteínas Fúngicas/genética , Glicerol/metabolismo , Glicerol Quinase/química , Glicerol Quinase/genética , Histidina/química , Histidina/genética , Histidina/metabolismo , Concentração de Íons de Hidrogênio , Cinética , Metanol/metabolismo , Oligopeptídeos/química , Oligopeptídeos/genética , Oligopeptídeos/metabolismo , Pichia/química , Pichia/enzimologia , Pichia/genética , Reação em Cadeia da Polimerase , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/genética , Temperatura
3.
J Biotechnol ; 124(2): 347-62, 2006 Jul 13.
Artigo em Inglês | MEDLINE | ID: mdl-16513199

RESUMO

The production of hantavirus Puumala nucleocapsid (N) protein for potential applications as a vaccine and for diagnostic purposes was investigated with Saccharomyces cerevisiae as a recombinant host. The N protein gene and the hexahistidine tagged N (h-N) protein gene were expressed intracellular from a 2-microm plasmid vectors under the control of a fused galactose inducible GAL10-PYK promoter. For monitoring the recombinant gene expression, a h-N and a GFP fusion protein was used. Different cultivation strategies and growth media compositions were tested in shake flasks and a 5 l bioreactor. When using defined YNB growth medium, we found the biomass yield to be unsatisfactorily low. Higher concentrated YNB medium, promoted cell growth but showed a pronounced inhibitory effect on heterologous gene expression. This phenomenon could not be attributed to plasmid losses, as we could demonstrate high stability of the vector under the applied cultivation conditions. Supplementation of YNB medium with extracts of plant origin resulted in increased biomass yields with concomitant high expression levels of the recombinant gene. The modified medium was used for fed-batch cultivations where basic metabolic features as well as growth parameters were determined in addition to recombinant gene expression. The maximal volumetric yield of N protein was 316 mg l(-1), the respective yield of h-N protein was 284 mg l(-1). Our study provides a basis for large-scale production of hantavirus vaccines, which satisfies economic efficiency as well as biosafety regulations for human applications.


Assuntos
Proteínas do Nucleocapsídeo/biossíntese , Virus Puumala/imunologia , Proteínas Recombinantes/biossíntese , Saccharomyces cerevisiae/metabolismo , Vacinas Virais/biossíntese , Biomassa , Meios de Cultura/química , Meios de Cultura/metabolismo , Vetores Genéticos/genética , Glucose/metabolismo , Virus Puumala/genética , Saccharomyces cerevisiae/genética , Vacinas de Subunidades Antigênicas/biossíntese
4.
Z Naturforsch C J Biosci ; 53(5-6): 325-30, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9679324

RESUMO

Acriflavine treatment on Streptomyces tendae generated a bald mutant (bld-1) with an altered antibiotic pattern. The parental strain produced nikkomycins and juglomycins, whereas the mutant bld-1 was only capable of juglomycin synthesis. The existence of a mutant defective in morphogenesis and in nikkomycin biosynthesis suggests a common regulation of these processes. An interesting finding of this study is that mutant bld-1 produced two carbazole derivatives, hitherto never seen in cultures of the parental strain. It seems likely that the DNA intercalating dye acriflavine, by mutagenesis, had activated cryptic genes which are involved in carbazole synthesis. The two carbazole derivatives were identified as the neuronal cell protecting compounds CS-79B and carquinostatin A, recently isolated from a wild-type of S. exfoliatus. We found that both substances showed antibacterial activity.


Assuntos
Aminoglicosídeos , Antibacterianos/biossíntese , Streptomyces/genética , Streptomyces/metabolismo , Acriflavina/farmacologia , Antibacterianos/química , Antibacterianos/farmacologia , Bactérias/efeitos dos fármacos , Carbazóis/química , Carbazóis/isolamento & purificação , Carbazóis/metabolismo , Carbazóis/farmacologia , Testes de Sensibilidade Microbiana , Morfogênese , Mutagênese , Naftoquinonas/metabolismo , Naftoquinonas/farmacologia , Fármacos Neuroprotetores , Streptomyces/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...